These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors. Adjei AA Ann Oncol; 2000 Oct; 11(10):1335-41. PubMed ID: 11106124 [TBL] [Abstract][Full Text] [Related]
4. Pemetrexed disodium (Eli Lilly). Norman P Curr Opin Investig Drugs; 2001 Nov; 2(11):1611-22. PubMed ID: 11763166 [TBL] [Abstract][Full Text] [Related]
5. Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent. Solomon B; Bunn PA Future Oncol; 2005 Dec; 1(6):733-46. PubMed ID: 16556051 [TBL] [Abstract][Full Text] [Related]
6. Pemetrexed: an active new agent for breast cancer. O'Shaughnessy JA Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology and mechanism of action of pemetrexed. Adjei AA Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S51-5. PubMed ID: 15117425 [TBL] [Abstract][Full Text] [Related]
8. Pemetrexed disodium, a novel antifolate with multiple targets. Curtin NJ; Hughes AN Lancet Oncol; 2001 May; 2(5):298-306. PubMed ID: 11905785 [TBL] [Abstract][Full Text] [Related]
10. Clinical Experience With Pemetrexed in Breast Cancer. Martin M Semin Oncol; 2006 Feb; 33(Suppl 2):S15-8. PubMed ID: 16472713 [TBL] [Abstract][Full Text] [Related]
14. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors). Bunn PA Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334 [TBL] [Abstract][Full Text] [Related]
15. Pemetrexed and its emerging role in the treatment of thoracic malignancies. Scagliotti GV; Novello S Expert Opin Investig Drugs; 2003 May; 12(5):853-63. PubMed ID: 12720495 [TBL] [Abstract][Full Text] [Related]
16. Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent. Adjei AA Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4276s-4280s. PubMed ID: 15217974 [TBL] [Abstract][Full Text] [Related]
17. Pemetrexed (Alimta): a promising new agent for the treatment of breast cancer. Calvert H Semin Oncol; 2003 Apr; 30(2 Suppl 3):2-5. PubMed ID: 12722017 [TBL] [Abstract][Full Text] [Related]